Ratings COMPAGNIE FINANCIERE RICHEMONT BOERSE MUENCHEN

Equities

RIT1

US2043191079

Market Closed - BOERSE MUENCHEN Other stock markets 20:43:58 03/07/2024 BST			5-day change	1st Jan Change
14.4 ^EUR	-1.37%		-2.67%	+18.70%

07-02	Richemont Reshuffles Core Jewelry Division Leadership -- 2nd Update	DJ
07-02	Richemont: new CEO for Van Cleef & Arpels in September	CF

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

The company's enterprise value to sales, at 3.43 times its current sales, is high.
In relation to the value of its tangible assets, the company's valuation appears relatively high.

Ratings chart - Surperformance

Sector: Apparel & Accessories

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
COMPAGNIE FINANCIERE RICHEMONT	+18.70%	92.16B		-
TITAN COMPANY LIMITED	-8.57%	36.16B		C
PANDORA A/S	+6.88%	11.62B		A-
CHOW TAI FOOK JEWELLERY GROUP LIMITED	-28.66%	10.35B		B+
LAO FENG XIANG CO., LTD.	-13.80%	3.38B		-
CHINA NATIONAL GOLD GROUP GOLD JEWELLERY CO.,LTD.	-3.14%	2.22B		-
CHOW TAI SENG JEWELLERY CO., LTD.	-13.18%	1.97B		D+
LAOPU GOLD CO., LTD.	0.00%	1.63B	-	-
BEIJING CAISHIKOU DEPARTMENT STORE CO.,LTD.	-15.31%	1.35B		-
DR CORPORATION LIMITED	-35.13%	1.04B		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes